Review Article | Open Access
Skin Basement Membrane: The Foundation of Epidermal Integrity—BM Functions and Diverse Roles of Bridging Molecules Nidogen and Perlecan
The epidermis functions in skin as first defense line or barrier against environmental impacts, resting on extracellular matrix (ECM) of the dermis underneath. Both compartments are connected by the basement membrane (BM), composed of a set of distinct glycoproteins and proteoglycans. Herein we are reviewing molecular aspects of BM structure, composition, and function regarding not only (i) the dermoepidermal interface but also (ii) the resident microvasculature, primarily focusing on the per se nonscaffold forming components perlecan and nidogen-1 and nidogen-2. Depletion or functional deficiencies of any BM component are lethal at some stage of development or around birth, though BM defects vary between organs and tissues. Lethality problems were overcome by developmental stage- and skin-specific gene targeting or by cell grafting and organotypic (3D) cocultures of normal or defective cells, which allows recapitulating BM formation de novo. Thus, evidence is accumulating that BM assembly and turnover rely on mechanical properties and composition of the adjacent ECM and the dynamics of molecular assembly, including further “minor” local components, nidogens largely functioning as catalysts or molecular adaptors and perlecan as bridging stabilizer. Collectively, orchestration of BM assembly, remodeling, and the role of individual players herein are determined by the developmental, tissue-specific, or functional context.
In skin the epidermis represents the outer barrier of the organism, providing protection against physical, chemical, and microbial impacts of the environment. It should be mentioned beforehand that skin in general is serving multiple other functions (e.g., sensing touch, pain, temperature, and priming immune responses), thus representing our second largest organ only surpassed by the vascular system. However, these other issues are beyond the scope of this paper. The skin consists of two morphologically distinguishable compartments, the epidermis and the dermis, which communicate in various ways and at different levels to establish, maintain, or restore tissue homeostasis. While in skin the dermis bears the main mechanical load and provides also insulation, the vital barrier function at the outer surface is accomplished by the epidermis which is a constantly renewing, stratifying, and keratinizing epithelium [1, 2]. Special lipids and tight junctions between epidermal cells (keratinocytes) in upper layers prevent penetration or loss of water [3, 4], and finally the formation of cornified envelopes, an alloy of highly cross-linked proteins and proteolipids, is warranting chemical resistance [5–9]. Mechanical resistance of the epidermis relies on the intracellular keratin filaments which form via epithelia-specific junctions, the desmosomes a large, continuous intraepithelial network ([2, 4, 10] detailed reviews). The dermal tensile strength and elasticity are defined by its extracellular matrix (ECM) properties with type I and III collagen fibrils, microfibrils, and elastic fibers, embedded in a ground substance of proteoglycans . The boundary between the two skin compartments provides the basal lamina or basement membrane (BM), a highly specialized ECM structure, which physically separates the two compartments rendering primarily a stabilizing, though still dynamic interface and a diffusion barrier [12–19].
Besides their prominence in skin, BMs support all epithelia and endothelia, enwrap Schwann cells and nerve extensions [20, 21], muscles [22, 23], tissue compartments like fat, and whole organs . With highly specialized modifications BMs are essential for function in the glomeruli of the kidney [24–26], in nerve synapses , and neuromuscular junctions [23, 28–30]. Apart from structural properties, the dermoepidermal BM has gate-keeping functions which control cell traffic and diffusion of bioactive molecules in both directions. In addition, the BM is binding a variety of cytokines and growth factors, serving a reservoir for their controlled release [31–34]. This plays a crucial role during physiological remodeling or repair processes after injury, while under pathologic conditions such as inflammation the release of factors is further enhanced due to vast BM destruction, being also part of the activating stroma reaction in cancer [35, 36]. Thus, the pivotal role of altered cell interactions with ECM becomes especially apparent in healing wounds or in invading tumors, where epithelial cells are confronted with other, newly accessible ECM molecules, their proteolytic fragments, or cleavage sites (neoepitopes) in the surrounding stroma [37–40]. Main cell surface mediators of those cell matrix interactions are α-/β-dystroglycan [41–44], syndecans [29, 45–47], and certain integrins being members of a large family of heterodimeric transmembrane proteins ([48–51]; for general review: ). Integrins are intracellularly associated via adapter proteins with actin microfilaments, which is crucial for both cell adhesion and migration, becoming particularly apparent in tumor invasion and metastasis ([52, 53]; reviewed by ), and ECM-mediated signalling [55–59]. The only exception is integrin α6β4 which is normally connected to the basal part of the keratin network via the long cytoplasmic tail of the β4 subunit and internal plaque proteins (outlined later). Thus, during BM assembly α6β4 becomes an integral part of hemidesmosomes which represent the firm epidermal adhesion points to the BM [60–62]. In the normal balanced state integrins show a polarized distribution, integrins α2β1 and α3β1 covering lateral and ventral surfaces of basal cells, while α6β4 is largely restricted to the ventral site opposed to ECM or BM [48, 49, 51]. Strikingly, in skin wounds or tumors the pericellular integrin distribution, including then also α6β4, largely expands into suprabasal layers, which reflects a severe reduction in cell and tissue polarity [63–65]. Last not least, particular properties or microheterogeneity of BMs is supposed to contribute to the niche of tissue-specific stem or progenitor cells [66–72].
2. Molecular Building Blocks of Basement Membranes
In general, BMs contain at least one member of the four protein families or subtypes of laminin, type IV collagen, nidogen, and perlecan, a heparan sulfate proteoglycan ([14, 73, 74]; for review: [19, 75, 76]) which determines their common structure. To some extent the tissue-specific functional diversity is accomplished by differential expression of respective isoforms [16, 31, 77–80]. As the principal structural elements, laminin and collagen IV form distinct networks  which become noncovalently interconnected by mono- or oligomeric nidogen [41, 82, 83] and perlecan, able to form irregular polymers [74, 84] (Figures 1(a) and 1(b)). Additional components may be involved as well such as fibrillin [85, 86], collagen V , perhaps also the BM-associated collagens XV and XVIII [31, 88] and extracellular matrix protein 1/ECM1 [89, 90]. Most of the laminin isoforms are able to self-assembly occurring via the N-terminal globular domains at the short arms of their α, β, and γ chains by noncovalent bonds, forming large two-dimensional sheets ([19, 78, 81, 91, 92], also for review) (Figures 1 and 2(e)). This reversible interaction allows local disassembly when needed, for example, during tissue remodeling. Crucial for cell or tissue fate and function is cell adhesion to laminins with the main cell binding site residing in the C-terminal globular domain on the long arm of the α chain [14, 20, 93, 94]. The collagen IV molecules, on the contrary, are covalently cross-linked by disulfide bridges via their noncollagenous C- and globular N-terminus, giving rise to a very stable “chicken-wire”-like meshwork of high chemical resistance [14, 84, 95]. Thus, the mechanical BM robustness is mostly determined by the collagen IV scaffold , whereas for the initial steps of BM assembly in vivo laminin is essential [14, 97, 98].
As mentioned above, both nidogen and perlecan, not forming structured polymers, are bridging these scaffolds by their multiple binding sites for laminin and collagen IV, including the perlecan heparan sulfate chains , as well as for each other ([19, 99–103], also for review). Complete perlecan deficiency is lethal for mouse embryos at the midgestational stage [104, 105], and the deletion of both nidogens is perinatally lethal .
The predominating nidogen-1 [82, 83, 107] and the later discovered nidogen-2 as second mammalian isoform [108–110] are ubiquitous BM proteins though nidogen-2 shows more restricted expression patterns throughout development and some tissue specificity in adulthood (comprehensive review, ). Both isoforms interact in vitro with many other BM molecules, in particular laminin and collagen IV, implying nidogens as essential integrating elements for BM assembly [99, 101, 109, 110]. Thus, primarily nidogen has been considered as the main cross-linker between laminins and collagen IV, revealing very high affinity to the laminin γ1 chain [101, 112, 113] but also the γ3 chain [111, 114, 115]. Contrarily, a major regulatory role has been assigned to perlecan  which implements a high negative charge in BMs through its three heparan sulfate side chains, providing a diffusion barrier as well as anchoring port . However, a recent report has presented strong evidence that perlecan aggregates function as more stable connecting bridges  though the binding to laminin and collagen IV via the heparan sulfate chains seems to be of rather low specificity . According to the BM ultrastructure (Figures 2(b) and 2(c)) observed by transmission electron microscopy (EM; standard fixation), the laminin/collagen IV polymers form the body of the lamina densa below the “empty” lamina lucida, which has been confirmed by immune EM [12, 75, 117, 118]. At this point it should be noted that the lamina lucida is not detectable in EM specimens fixed by cryopreservation, indicating that the lamina lucida reflects rather an artificial structure than real BM topography. Spacing and actual orientation of BM molecules could be determined by applying epitope-specific antibodies . Anchorage of the epidermis to the BM (schematic view in Figure 2(a)) is accomplished by hemidesmosomes, consisting of the intracellular plaque proteins plectin and bullous pemphigoid antigen 1/BPAG1 [2, 119] which link the keratin filaments to the transmembrane proteins integrin α6β4 [60, 120], tetraspanin CD151 , and collagen XVII (BP180 and BPAG2; [122, 123]). Integrin α6β4, the only integrin associated with keratins, binds to laminin-332 (laminin-5; ) (colocalization shown in Figure 2(d)), which is not self-polymerizing and forms together with the extracellular domain of collagen XVII , the anchoring filaments spanning the whole BM. This requires specific molecular tailoring of laminin-332 by sequential proteolytic processing (Figure 2(e)) [65, 125–127]. Initially keratinocytes attach to unprocessed laminin-332 via integrin α3β1 (associated with the actin cytoskeleton), forming focal adhesion contacts, which promotes cell migration. Sequential cleavage of distinct laminin modules leads to strong cell adhesion via α6β4 and hemidesmosome formation (“laminin-5r”; [128, 129]). Contrarily, further truncation of laminin-332 during wound regeneration or tumor invasion promotes again cell motility [78, 125, 130–132]. Tetraspanin CD151 seems to mediate the transitions between these stable and dynamic cell-matrix contacts [119, 121, 133], which is also involved in tumor cell migration . Several proteases seem to participate in these processes, for example, plasmin [50, 126], matrix metalloproteinases like MMP-2, -3, -14/MT1-MMP [135, 136] and other astacin family members like bone morphogenetic protein 1/BMP1, mammalian tolloid/mTLD, and mammalian tolloid-like metalloproteases/mTLL . Some divergence between data may relate to the tissue type or state such as physiologic or pathologic turnover, activation by inflammatory reactions, or tumor invasion and metastasis, upregulating MMPs like MMP-14  and in many tumors the surface-protease hepsin .
The BM is connected to the dermis underneath by anchoring fibrils, loop structures of collagen VII, which bind to laminin-332 by their NC-1 domains  and are interwoven with the fabric of collagen I and III fibrils [139–141]. Collectively these adhesion complexes are essential for the structural and functional integrity of skin . Thus, inherited or acquired defects of those BM or BM-associated molecules result mostly in severe or lethal blistering diseases [139, 142, 143].
For the following it should be explicitly stated that in skin the components collagen IV and VII, and perlecan are synthesized by both epidermal keratinocytes and dermal fibroblasts, while the main source of nidogens are the fibroblasts [144–146] and of laminin-332 and -511 the keratinocytes [125, 144]. The first detectable isoform in the embryo laminin-111 is predominant in BMs during early development and is in most BMs like in skin successively replaced to a large extent by laminin-511. That is crucial for organogenesis and becomes the most abundant isoform in the adult organism [41, 147, 148]. Similarly laminin-211, a minor component in embryonic skin, is in adult skin only transiently synthesized after wounding, though exclusively by dermal fibroblasts (also for general review: [14, 78, 94, 103, 149]). A wider laminin-111 distribution in embryonic tissues suggested in earlier reports was due to the erroneously assigned specificity of a monoclonal antibody (4C7) to the laminin α1 instead of the α5 chain [22, 150, 151].
3. Identification of Molecular BM Defects by Genetic Approaches
Since defects in the structural components of BM, that is, respective laminins and collagen IV, are not compatible with early embryonic development, we like to focus here mainly on deletions or functional defaults of the bridging molecules nidogen and perlecan. Complete perlecan deficiency is lethal for mouse embryos at the midgestational stage primarily due to heart failure [104, 105]. Besides anomalies in cartilage and bone formation, particularly vascular BMs were seriously affected which presumably explains the extensive internal bleeding for vessel leakiness. Generally, perlecan is very important for developmental angiogenesis, so the deficiency of that could be largely responsible for organ failure in these embryos [34, 116].
Genetic ablation of nidogen-1  or nidogen-2  alone did not cause obvious BM alterations. However, in nidogen-1 null mice, a redistribution and increase of nidogen-2 are observed, for example, in skeletal and heart muscle or nerves suggesting that generally nidogen-2 can compensate the loss of nidogen-1 for BM formation [152, 154]. Nevertheless, nidogen-1 null mice show certain developmental and neurological defects indicating only partial redundancy [155–157]. Mice lacking both nidogens die perinatally from lung and heart anomalies, directly related to BM defects, while in most other tissues including the dermoepidermal junction in skin BMs they appear largely unaffected [17, 106]. The crucial role of nidogens in organ development was also confirmed in embryonic tissue models in vitro [113, 145]. At birth the skin of nidogen-null mice fulfills regular barrier functions revealing no obvious water loss (inside out) and complete resistance against dye penetration (outside in). However, examining skin ultrastructure some abnormal-looking basal cells were observed as well as microblistering and leakiness of small vessels (detailed later on). Interestingly, mice with deletion of the nidogen binding site on the laminin γ1 chain showed specifically defects of the urogenital tract, kidney, and lung but not any detectable anomalies of the cutaneous and capillary BMs . Presumably that is due to compensation by nidogen-2 which is in contrast to nidogen-1 retained within the BM, implying alternative binding sites , while in addition the presence of laminins with a γ3 chain, harboring respective binding sites, may play a role as well.
Another, apparently restrictive, regulator of BM assembly “extracellular matrix protein 1”/ECM1 came across when analyzing skin biopsies of lipoid proteinosis (LP) patients with mutations in the ECM1 gene (see [89, 90, 159]). The most striking clinical symptoms are hoarseness of the voice and mild, but progressive, mental retardation. Biopsies of scaling skin lesions revealed multiple BM duplications  and severe microvascular aberrations, marked by huge concentric BM deposits around small vessels, frequently leading to luminal collapse (; see below).
4. Incomplete Epidermal Reconstruction by Isolated Human Cells in Conventional Culture
Epidermal keratinocytes and dermal fibroblasts, representing the two main cell types of skin, have been analyzed extensively by cell culture in vitro for studies on skin physiology, repair, and tumorigenesis. However, major drawbacks of those approaches are that (i) both cell types behave very differently in conventional cultures on plastic dishes and (ii) in addition they intensively communicate with each other or the ECM in vivo which regulates growth and gene expression determining the skin phenotype. In the dermis fibroblasts are embedded in ECM (collagen, fibronectin, and proteoglycans) and acquire a spindle-shaped morphology , being only connected over long cell extensions via gap junctions , which differs completely from their flattened shape in vitro. Differently, keratinocytes form coherent cell layers in vitro like in vivo, undergoing epidermal differentiation. However, this process is incomplete and resembles somehow a regenerating wound epithelium. To a great part this is due to the conventional (two-dimensional) culture conditions, where the direction of nutrient supply is reversed from basal cell attachment sites in vivo (at the BM, facing dermis) to the upper epithelial surface (in vivo providing the water barrier). Despite of the different physiology of human and adult mouse skin, these changes were comparable in keratinocyte cultures from newborn mouse or human tissue [160–162]. An important achievement for the development of human cell models was the establishment of the human epidermal cell line HaCaT . Like normal keratinocytes HaCaT cells respond to the induction of differentiation processes, for example, by growing cultures to very high cell densities, raising Ca2+, or lowering retinoid levels [5, 164, 165]. On the contrary, benign and malignant HaCaT-ras variants (containing a mutated Ha ras-gene) generally maintained their more complex, atypical keratin profiles in vitro, by and large related to their tumorigenic properties (see below; [164–166]).
5. Human Cells Rebuild Epidermal Architecture in Mouse Xenografts
Transplants of cultured mouse keratinocytes on the back of immune compatible mice had demonstrated the full differentiation potential of these cells, exposing them again to an authentic microenvironment [160, 161]. Likewise keratinocytes from human skin, hair follicle/outer root sheath cells, or HaCaT cells transplanted on nude mice ([163, 167–170]; also for further references) were able to restore epidermal tissue showing regular differentiation. Keratin patterns were normalized; that is, basal cells expressed keratin K5/14 and cells in the layers above keratin K1/10, followed by late differentiation markers, responsible for epidermal barrier function. The full restoration of epidermal architecture matched with the formation of a regular BM and mature hemidesmosomes [169, 170]. Monitored by immunofluorescence, the BM components were laid down sequentially, laminin-332 appearing first, shortly followed by nidogen, and with some delay by a γ1 chain laminin, presumably laminin-511, and collagen IV. Accordingly integrins, initially decorating cell surfaces in lower layers, became restricted in distribution, that is, β1 integrins to the basal cell surface and α6β4 mainly to the cell-matrix interface. Furthermore cell proliferation decreased as visualized by BrdU uptake, finally labelling about 5% of basal cells, a rate seen in normal epidermis  which is compatible with a role of BM in epidermal growth regulation. The gradual formation of the BM zone and epidermal-BM anchoring structures was confirmed at the ultrastructural level by EM, which underlines, together with immunostaining, that certain threshold levels of BM constituents are required for complete assembly.
In order to study tumor-related defects of epidermal anchorage (BM, hemidesmosomes), tissue polarity, and differentiation in an experimental human tumor model benign and malignant HaCaT-ras cells were transplanted on nude mice, revealing unbalanced, but non-invasive or invasive, tissue-destructive growth, respectively [64, 171]. Reflecting mutual interactions with the changing stromal support, even malignant HaCaT-ras cells formed initially well polarized, differentiating epithelia with some remnant BM structures. However, this was changing dramatically with the mounting tumor-stroma reaction, showing in close correlation to the malignant properties the persistence of inflammatory cell infiltration and angiogenesis [35, 172], commonly downregulated in benign cell grafts or late wounds. Consequently, epithelial polarity declined showing irregular clusters of proliferating and differentiating cells. As hallmark, seen in skin squamous cell carcinomas , nonepidermal “simple” keratins K8/K18 and vimentin (an indicator for epithelial-mesenchymal transition/EMT) appeared at the invading front . The areas of proliferation, expanding suprabasally, were strongly decorated by β1-integrins and α6β4 , similar to changes observed in mouse models of two-stage carcinogenesis (; references in ). In the malignant cell grafts regular BM structures were completely disappearing, whereas laminin-332 increased aberrantly lining also lateral cell surfaces and deep epithelial clefts which was preceeding invasive growth. Nevertheless BM components and anchoring structures were still detectable by immune EM though they were displaced and diffusely distributed . Comparable changes in laminin-332 or γ2 chain expression and location have been observed in squamous cell carcinomas of human skin and other carcinomas ([176, 177]; for review ).
6. Organotypic (3D) Cocultures Forming Artificial Skin In Vitro
In contrast to conventional culture models with their fundamental limitations regarding the relevance for skin physiology or pathology, the tissues generated by cell grafts on mouse are very complex, depending also largely on systemic effects and inflammatory host responses. To provide a better defined, simpler experimental system which still mimics the basic criteria of skin physiology, organotypic cocultures were established based on essential elements of skin [146, 178–183]. In this three-dimensional (3D) coculture system keratinocytes grow on collagen I matrices populated with dermal fibroblasts, using filter inserts and multiwell culture devices. Epithelial polarity is achieved by the media supply from underneath and epithelial surface exposure to air, that is, the incubator gas phase. While simulating the constellation in skin or keratinocyte transplants, the 3D model allows supplementation with diffusible molecules or factors, providing a controlled, closed system. Furthermore, genetically manipulated mouse or human cells, including presumptive progenitor or stem cells, can be combined which has been demonstrated for cells with deleted, silenced, or inducible gene expression [32, 103, 118, 149, 184–187]. With several combinations of normal cells from different sources, including human hair follicle, a regular epidermal phenotype could be reconstituted expressing respective differentiation markers [168, 183, 188] and normal BM structures [89, 180, 181, 183, 189–191]. This setup provides also an attractive alternative to test functions of mutated or gene manipulated cells of patients with BM/junctional defects for applications in gene therapy [141, 192, 193].
7. Distinct Functions of Perlecan and Nidogen Reconstructing a Dermoepidermal Interface
As stated already, perlecan is made by both cell types, while nidogen-1 and -2 originate from fibroblasts and the BM-associated laminin-332 and -511 (in skin) from keratinocytes [144, 146, 149, 191]. In the 3D model ablation of “dermal” perlecan had no deleterious effect on BM deposition or epithelial morphology, when using fibroblasts from perlecan-null embryos  with normal HaCaT cells . Also the combination of perlecan deficient HaCaT cells (expressing perlecan antisense RNA) with wild-type fibroblasts (producing perlecan) had no effect on BM deposition as judged by light microscopy. However, a markedly delayed onset of epithelial growth was observed, while regular epidermal structures developed eventually . This indicates that at least in this model perlecan has no effect on initiating BM assembly though firm perlecan incorporation in skin BM has been reported very recently . Besides this apparently more stabilizing function, perlecan is certainly indispensable for functional BM properties such as control of balanced growth and other signaling cues [33, 116, 194]. Interestingly, total perlecan deficiency in the 3D model did not interfere with proliferation but dramatically enhanced the apoptosis of the epithelial cells . Nidogen seemed to have a diametrically opposed effect in this regard. Whereas epithelial growth and differentiation remained virtually normal in the complete absence of nidogen or when interfering with nidogen interactions, this was devastating for deposition and assembly of BMs in the 3D model as outlined in detail below.
8. Nidogen Plays an Essential Role for BM Assembly In Vitro
For bridging of laminin and collagen IV networks nidogen-laminin binding had been assumed to be the initial step [99, 101, 108, 109]. Apart from those reports, this was also concluded from early appearance of nidogen together with laminin-111 in development ahead of a visible BM , BM assembly on live cells [14, 81], and the early deposition of nidogen at the dermoepidermal interface seen in cell grafts [169, 170]. Thus, as first functional proof in 3D coculture we interfered with this interaction by employing a laminin γ1 fragment (γ1III3-5 module) harboring the binding site in the γ1III4 module [112, 195]. Repeated application abolished the deposition of nidogen as well as laminin and perlecan at the matrix interface when examined by indirect immunofluorescence. Other components, such as laminin-332, collagen IV, and integrin α6β4 were only moderately affected, showing still a distinct continuous staining at the interface. BM assembly could be reverted by delayed onset or reactivated by the discontinuation of the treatment, respectively, demonstrating the dynamics of this process. So, already assembled BM structures disappeared again by late treatment with the γ1 fragment, while BM formation was resumed when treatment was halted. Epidermal morphology and differentiation remained largely normal as judged by staining for K1/K10 and “late” markers. Examining ultrastructure revealed that the γ1 fragment completely blocked BM formation (no lamina densa visible) and further abolished the formation of hemidesmosomal adhesion complexes. Consequently keratin filaments retracted from the ventral cellular aspect, while basal cells adhered directly to “dermal” collagen fibrils.
Remarkably, immune EM revealed that BM constituents and hemidesmosomes were still present, though somewhat reduced and widely dispersed. This was in line with analyzing protein extracts of separated dermal and epidermal parts of cocultures. Thus, the major BM components nidogen-1, collagen IV, laminin-511 (laminin-10), and laminin-332 were detected by immunoblotting at similar levels with no signs of aberrant processing (; compare nidogen-null below). Collectively the major defects observed in this setting were the lack of BM and epidermal adhesion structures, basal dissociation of the keratin network, and direct basal cell contacts to type I collagen fibrils.
In order to demonstrate alternatively a direct role of nidogen itself, fibroblasts from knockout mice lacking either one or both nidogens were employed in 3D cocultures . Like the blockage of binding , absence of both nidogens totally impaired BM deposition and structural assembly, while the amounts of all other BM components remained unchanged as shown by immunoblotting. This in addition confirmed that also under those conditions no measurable compensatory nidogen synthesis occurred in the keratinocytes. Similarly, immune EM revealed scattered distribution of BM components over a broader area, escaping detection by immunofluorescence. Furthermore, a dosage effect was observed using fibroblasts from heterozygous or homozygous nidogen-deficient mice which synthesize different, reduced nidogen levels. The functional potential of the two nidogens could be ultimately proven by supplementing nidogen-depleted 3D cocultures with either recombinant nidogen-1 or -2. Both restored the BM zone seen by immunofluorescence or EM showing a regular ultrastructure, underlining the functional redundancy between both nidogens for the assembly processes . However, more recent studies, applying distinct binding domains of either nidogen-1 or -2 for BM reconstitution, provide clear evidence for distinct binding activities which may participate in tissue- or organ-specific effects not readily apparent by former molecular binding studies .
The striking differences between dermoepidermal BM formation in situ and in 3D cocultures indicate that tissue-related molecular modifications or “minor” components may play a role in addition to chemical and mechanical properties of the dermal ECM. Still another factor, not favoring BM assembly in this 3D model, is the low collagen I concentration in comparison to dermis and the relatively large volume of culture medium, both allowing fairly free diffusion of BM molecules. This is limiting the critical concentrations required for polymerization and assembly of BM structures, an effect recently termed “molecular crowding” . Actually this might enhance the effects of nidogens in 3D cocultures, apparently catalyzing or stabilizing initial molecular interactions for BM formation which should be also more crucial for BM repair or remodeling in vivo . Nevertheless, it has to be stated that BMs can per se develop in vivo in the absence of nidogens, however, with some restrictions and not in all organs suggesting a tissue-specific requirement for nidogens. According to recently reported immune EM studies, in skin laminin and collagen IV network were more intensely linked by perlecan aggregates than by nidogens which may reflect a progressed state of BM maturation . This could also mean that the supramolecular structures of collagen IV and laminin-511 are more divergent than commonly assumed, revealing a general decrease of laminin-511 or -521 in BM of adult versus juvenile skin , higher levels being restricted to the space below hemidesmosomes . In addition, there is clear evidence for other than structural BM functions (i.e., as crosslinker or adapter) of nidogen which apparently involves signaling events though both may be interlinked. Just giving a few examples: nidogen has been reported to rescue mammary epithelial cells from apoptosis  and, bound to laminin-111, to enhance laminin-driven gene expression and differentiation in the mammary gland . In the epidermal 3D coculture model nidogen deposition closely correlates with the restriction of epidermal cell growth , and on the other hand it accelerates epidermal wound repair . It is tempting to speculate that nidogen exerts that effect by acting as adapter or changing conformation of laminin, which could also apply to the revival of epidermal growth potential or stemness by laminin-511/-521 [66, 197] which may relate to protective effects on embryonic stem cells . Of particular interest is also that nidogen-1 specifically participates in nerve path-finding while its ablation is causing seizures ([17, 115, 152, 155], also for review). Further, nidogen has been localized in neuromuscular junctions in C. elegans, together with collagen XVIII playing an important role for structural organization . At least some of these effects should be mediated by binding of nidogens or such complexes to integrins like α3β1 or αvβ3 [201–203] or to other cell surface receptors ([29, 44, 46], for general review ).
9. Cutaneous Microvasculature Is More Severely Affected by Molecular BM Defects
Macroscopically and histologically, the skin of mice lacking both nidogens appears to be fairly normal, showing no anomalies of the dermoepidermal BM by immunofluorescence . Only some abnormal looking basal cells, rare microblisters, and slightly smaller hemidesmosomes (on average) have been observed by EM (E18.5; ). Because pups are dying around birth, one could only speculate what the later fate of epidermis might be during the transition from newborn to adult mouse skin with a dense hair coat and a much thinner epidermis. Unfortunately, the generation of mice with skin-specific nidogen deletion for further follow-up studies seems to be rather problematic and is currently not available (RN, data on reproduction of transgenic mice). In contrast to their intact cutaneous BM, the nidogen-deficient fetuses or newborns revealed mild intradermal bleedings indicating some microvascular defects. According to immune staining, in small vessels a defined BM was largely missing and instead an irregular, patchy pattern was observed with marked reduction of collagen IV, perlecan, and particularly of laminin-411 (laminin-8). As seen by ultrastructure, small blood vessels had thin leaky walls, completely lacking a distinct BM, showing dissociation of perivascular cells/presumptive pericytes and extravasation of erythrocytes . This closely resembles the small leaky vessels around experimentally induced human skin tumors of squamous cell carcinoma type in nude mice [172, 175]. Nidogen destabilization or turnover may also be involved in vessel sprouting. This was markedly enhanced when we injected beads with adsorbed laminin γ1III3-5 fragments (blocking nidogen binding) next to those experimental tumors in nude mice (DB, unpublished data).
Collectively the data indicate that in skin primarily the laminin composition of the two BM types (Figure 2(e)) dictates if nidogens are required or not for BM assembly or stabilization. Laminin-511 (with three short arms for self-assembly) is generally absent in tip cells of sprouting vessels [80, 204–206] and also, according to our data, in small vessels of mice directly after birth, containing at that time point mainly laminin-411 which is unable to form networks by self-polymerization (Figure 2(e); ). Contrarily, larger vessels normally having both laminins display a regular BM also in absence of nidogens. Of note, additional, “associated” collagen types like collagen XV and XVIII  seem to regulate the thickness of the collagen IV mat and thus of BMs. Interestingly, proteolytic fragments of all three collagen types or perlecan restrict angiogenesis especially in cancer [209–216], which may concurrently normalize the tumor microvasculature and reduce vessel leakiness as observed previously when interfering with experimental tumor angiogenesis . Interestingly in this context, laminin-332 has also been detected in tumor vessels and stromal cells like myofibroblasts, thus providing guiding tracks for migrating tumor cells in metastasis or anchorage for cell arrest, respectively, at vessel walls and distant secondary sites [37, 38, 40, 217].
A reverse picture was seen in skin biopsies of lipoid proteinosis (LP) patients. In this disorder dysfunction or lack of ECM1 causes excessive BM deposition at the dermoepidermal junction but most pronounced around small vessels, where these enormously sized, multiple BMs obviously impair vascular function ([117, 159]; also for review, [89, 90]). Ultrastructurally, the epidermal adhesion structures/anchoring fibrils below hemidesmosomes (composed of collagen VII; schematic view in Figure 2(a)) were markedly displaced though components like laminin-332 and collagen VII remained partially associated . Concerning functional consequences, a crucial role of both collagen VII and processed laminin-332 (including the C-terminal α3 G45 fragment) has been proposed for invasiveness of carcinomas in several reports, which rather show an extensive turnover of other BM components [65, 218, 219]. Albeit this issue is still controversial, since patients with recessive dystrophic epidermolysis bullosa, lacking regular collagen VII expression can still develop invasive skin tumors .
10. Summary and Further Outlook
For skin barrier function the regular structural organization of the epidermis is an unequivocal requirement which depends on an intact BM as anchor and support. The current state of the art allows no simple answer for ultimate molecular mechanisms to build up a fully functional BM. Being classically placed in the center of BM assembly the two nidogen isoforms revealed in the in vitro skin model that they can both induce and accelerate BM formation including epidermal BM adhesion structures. Furthermore the data strongly suggest that nidogens also function as instant stabilizers of molecular interactions, which is particularly important for fast tissue or BM remodeling. Perlecan, on the other hand, apparently provides more spacious links between laminin and collagen IV networks (“spot-wedded,” ) which may be also beneficial for BM texture and mechanical properties under steady-state conditions. An interesting question would be, if this spacing corresponds to the increased laminin-511 deposition beneath hemidesmosomes, demonstrated previously . So it would be further of great interest if the nidogen concentration closely follows this proposed spotty laminin-511 arrangement.
The combination of genetic and 3D coculture approaches in future studies appears promising to define further isoform-specific effects, as reported for laminin-511/521  and molecular interactions playing a role in skin physiology, formation of appendages, and skin pathology [54, 197, 221, 222]. Other players like ECM1  or “minor” collagens like type V , XV, and XVIII [31, 88] shall be considered as well, as they may serve as organizers or nucleus for BM assembly or implement BM microheterogeneity. The latter could be of particular relevance for the postulated epidermal stem cell niche [68, 223–227]. Thus, there is substantial evidence for direct influences of ECM or BM properties on stem cell fate or behavior [66, 69–72] which basically applies for other tissue-specific, precursor, or mesenchymal stem cells [228, 229] and embryonic stem cells as well . In this respect a crucial step forward has been recent improvements of the “dermal” part of this 3D model, approaching physiological and mechanical features of an authentic dermis [188, 231], while BM production in particular may be further enhanced by specific supplements . To explain the discrepancies between the in vitro and in vivo models, a promising task would be the generation of mouse strains with skin-specific constitutive or inducible ablation of both nidogens. Though not an easy task, this would permit to study BM formation or stability and epidermal barrier function in adult animals avoiding the deleterious systemic drawbacks. Last not least it is of great medical interest that compromised BM structures in tissues and the vascular system are a major hallmark of cancer progression and invasiveness. Nidogens exhibit a rather high susceptibility against proteases like matrix metalloproteases [195, 233], meprins [234, 235], or cathepsin S  getting highly activated in tumors. As such nidogens could serve at the front line as targets for early attacks leading to the destruction of tissue barriers and vascular leakiness facilitating tumor cell spreading and metastasis.
To a large part the work was supported by the Deutsche Forschungsgemeinschaft through the SFB 829 at the University of Cologne and the individual Grants NI-304/11-1 (RN) and BR-530/8-1 (DB); further support was provided by industrial grants (DB) (Sanofi-Aventis). The authors especially like to thank all students and colleagues involved in or contributing to these studies at any stage, last not least by critical and constructive discussions. They apologize to the many scientists whose publications we were unable to cite for obligatory space constraints.
- E. Fuchs and S. Raghavan, “Getting under the skin of epidermal morphogenesis,” Nature Reviews Genetics, vol. 3, no. 3, pp. 199–209, 2002.
- C. L. Simpson, D. M. Patel, and K. J. Green, “Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis,” Nature Reviews Molecular Cell Biology, vol. 12, no. 9, pp. 565–580, 2011.
- J. A. Tunggal, I. Helfrich, A. Schmitz et al., “E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions,” The EMBO Journal, vol. 24, no. 6, pp. 1146–1156, 2005.
- C. M. Niessen, “Tight junctions/adherens junctions: basic structure and function,” Journal of Investigative Dermatology, vol. 127, no. 11, pp. 2525–2532, 2007.
- D. Hohl, U. Lichti, D. Breitkreutz, P. M. Steinert, and D. R. Roop, “Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid,” Journal of Investigative Dermatology, vol. 96, no. 4, pp. 414–418, 1991.
- A. E. Kalinin, A. V. Kajava, and P. M. Steinert, “Epithelial barrier function: assembly and structural features of the cornified cell envelope,” BioEssays, vol. 24, no. 9, pp. 789–800, 2002.
- R. L. Eckert, M. T. Sturniolo, A. M. Broome, M. Ruse, and E. A. Rorke, “Transglutaminase function in epidermis,” Journal of Investigative Dermatology, vol. 124, no. 3, pp. 481–492, 2005.
- M. Huber, G. Siegenthaler, N. Mirancea et al., “Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex,” Journal of Investigative Dermatology, vol. 124, no. 5, pp. 998–1007, 2005.
- L. M. Sevilla, R. Nachat, K. R. Groot et al., “Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier,” Journal of Cell Biology, vol. 179, no. 7, pp. 1599–1612, 2007.
- K. J. Green, S. Getsios, S. Troyanovsky, and L. M. Godsel, “Intercellular junction assembly, dynamics, and homeostasis,” Cold Spring Harbor Perspectives in Biology, vol. 2, no. 2, Article ID a000125, 2010.
- T. Krieg and M. Aumailley, “The extracellular matrix of the dermis: flexible structures with dynamic functions,” Experimental Dermatology, vol. 20, no. 8, pp. 689–695, 2011.
- J. R. McMillan, M. Akiyama, and H. Shimizu, “Epidermal basement membrane zone components: ultrastructural distribution and molecular interactions,” Journal of Dermatological Science, vol. 31, no. 3, pp. 169–177, 2003.
- J. R. McMillan, M. Akiyama, H. Nakamura, and H. Shimizu, “Colocalization of multiple laminin isoforms predominantly beneath hemidesmosomes in the upper lamina densa of the epidermal basement membrane,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 1, pp. 109–118, 2006.
- P. D. Yurchenco, P. S. Amenta, and B. L. Patton, “Basement membrane assembly, stability and activities observed through a developmental lens,” Matrix Biology, vol. 22, no. 7, pp. 521–538, 2004.
- P. D. Yurchenco and W. G. Wadsworth, “Assembly and tissue functions of early embryonic laminins and netrins,” Current Opinion in Cell Biology, vol. 16, no. 5, pp. 572–579, 2004.
- V. S. LeBleu, B. MacDonald, and R. Kalluri, “Structure and function of basement membranes,” Experimental Biology and Medicine, vol. 232, no. 9, pp. 1121–1129, 2007.
- S. Mokkapati, A. Baranowsky, N. Mirancea, N. Smyth, D. Breitkreutz, and R. Nischt, “Basement membranes in skin are differently affected by lack of nidogen 1 and 2,” Journal of Investigative Dermatology, vol. 128, no. 9, pp. 2259–2267, 2008.
- D. Breitkreutz, N. Mirancea, and R. Nischt, “Basement membranes in skin: unique matrix structures with diverse functions?” Histochemistry and Cell Biology, vol. 132, no. 1, pp. 1–10, 2009.
- P. D. Yurchenco and B. L. Patton, “Developmental and pathogenic mechanisms of basement membrane assembly,” Current Pharmaceutical Design, vol. 15, no. 12, pp. 1277–1294, 2009.
- K. K. McKee, D. Harrison, S. Capizzi, and P. D. Yurchenco, “Scaffold-forming and adhesive contributions of synthetic laminin-binding proteins to basement membrane assembly,” The Journal of Biological Chemistry, vol. 284, no. 13, pp. 8984–8994, 2009.
- K. Rasi, M. Hurskainen, M. Kallio et al., “Lack of collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, leads to basement membrane abnormalities and sensorimotor dysfunction,” Journal of Neuroscience, vol. 30, no. 43, pp. 14490–14501, 2010.
- C. F. Tiger, M. F. Champliaud, F. Pedrosa-Domellof, L. E. Thornell, P. Ekblom, and D. Gullberg, “Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies,” The Journal of Biological Chemistry, vol. 272, no. 45, pp. 28590–28595, 1997.
- V. Carmignac and M. Durbeej, “Cell-matrix interactions in muscle disease,” Journal of Pathology, vol. 226, no. 2, pp. 200–218, 2012.
- S. T. Kim, T. L. Adair-Kirk, R. M. Senior, and J. H. Miner, “Functional consequences of cell type-restricted expression of Laminin α5 in mouse placental labyrinth and kidney glomerular capillaries,” PLoS ONE, vol. 7, no. 7, Article ID e41348, 2012.
- J. H. Miner, “The glomerular basement membrane,” Experimental Cell Research, vol. 318, no. 9, pp. 973–978, 2012.
- A. Zhang and S. Huang, “Progress in pathogenesis of proteinuria,” International Journal of Nephrology, vol. 2012, Article ID 314251, 14 pages, 2012.
- T. Xiao, W. Staub, E. Robles, N. J. Gosse, G. J. Cole, and H. Baier, “Assembly of lamina-specific neuronal connections by slit bound to type IV collagen,” Cell, vol. 146, no. 1, pp. 164–176, 2011.
- B. D. Ackley, S. H. Kang, J. R. Crew, C. Suh, Y. Jin, and J. M. Kramer, “The basement membrane components nidogen and type XVIII collagen regulate organization of neuromuscular junctions in Caenorhabditis elegans,” Journal of Neuroscience, vol. 23, no. 9, pp. 3577–3587, 2003.
- Y. Choi, H. Chung, H. Jung, J. R. Couchman, and E. S. Oh, “Syndecans as cell surface receptors: unique structure equates with functional diversity,” Matrix Biology, vol. 30, no. 2, pp. 93–99, 2011.
- N. Singhal and P. T. Martin, “Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction,” Developmental Neurobiology, vol. 71, no. 11, pp. 982–1005, 2011.
- R. V. Iozzo, “Basement membrane proteoglycans: from cellar to ceiling,” Nature Reviews Molecular Cell Biology, vol. 6, no. 8, pp. 646–656, 2005.
- I. Sher, S. Zisman-Rozen, L. Eliahu et al., “Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation,” The Journal of Biological Chemistry, vol. 281, no. 8, pp. 5178–5187, 2006.
- V. N. Patel, K. M. Likar, S. Zisman-Rozen et al., “Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation,” The Journal of Biological Chemistry, vol. 283, no. 14, pp. 9308–9317, 2008.
- J. J. Zoeller, J. M. Whitelock, and R. V. Iozzo, “Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis,” Matrix Biology, vol. 28, no. 5, pp. 284–291, 2009.
- M. M. Mueller and N. E. Fusenig, “Friends or foes—bipolar effects of the tumour stroma in cancer,” Nature Reviews Cancer, vol. 4, no. 11, pp. 839–849, 2004.
- B. Wang, J. Sun, S. Kitamoto et al., “Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors,” The Journal of Biological Chemistry, vol. 281, no. 9, pp. 6020–6029, 2006.
- M. Franz, P. Richter, C. Geyer et al., “Mesenchymal cells contribute to the synthesis and deposition of the laminin-5 γ2 chain in the invasive front of oral squamous cell carcinoma,” Journal of Molecular Histology, vol. 38, no. 3, pp. 183–190, 2007.
- M. Franz, A. Wolheim, P. Richter et al., “Stromal laminin chain distribution in normal, hyperplastic and malignant oral mucosa: relation to myofibroblast occurrence and vessel formation,” Journal of Oral Pathology and Medicine, vol. 39, no. 4, pp. 290–298, 2010.
- C. M. Guess and V. Quaranta, “Defining the role of laminin-332 in carcinoma,” Matrix Biology, vol. 28, no. 8, pp. 445–455, 2009.
- P. G. Gritsenko, O. Ilina, and P. Friedl, “Interstitial guidance of cancer invasion,” Journal of Pathology, vol. 226, no. 2, pp. 185–199, 2012.
- P. Ekblom, “Receptors for laminins during epithelial morphogenesis,” Current Opinion in Cell Biology, vol. 8, no. 5, pp. 700–706, 1996.
- M. Durbeej, M. D. Henry, M. Ferletta, K. P. Campbell, and P. Ekblom, “Distribution of dystroglycan in normal adult mouse tissues,” Journal of Histochemistry and Cytochemistry, vol. 46, no. 4, pp. 449–457, 1998.
- C. Herzog, C. Has, C. W. Franzke et al., “Dystroglycan in skin and cutaneous cells: β-subunit is from the cell surface,” Journal of Investigative Dermatology, vol. 122, no. 6, pp. 1372–1380, 2004.
- C. Sirour, M. Hidalgo, V. Bello, N. Buisson, T. Darribère, and N. Moreau, “Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway,” Molecular Biology of the Cell, vol. 22, no. 16, pp. 2957–2969, 2011.
- T. Ogawa, Y. Tsubota, J. Hashimoto, Y. Kariya, and K. Miyazaki, “The short arm of laminin γ2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin β4 chain,” Molecular Biology of the Cell, vol. 18, no. 5, pp. 1621–1633, 2007.
- X. Xian, S. Gopal, and J. R. Couchman, “Syndecans as receptors and organizers of the extracellular matrix,” Cell and Tissue Research, vol. 339, no. 1, pp. 31–46, 2010.
- S. Carulli, K. Beck, G. Dayan, S. Boulesteix, H. Lortat-Jacob, and P. Rousselle, “Cell surface proteoglycans syndecan-1 and -4 bind overlapping but distinct sites in laminin α3 LG45 protein domain,” The Journal of Biological Chemistry, vol. 287, no. 15, pp. 12204–12216, 2012.
- U. Konter, I. Kellner, E. Klein, R. Kaufmann, V. Mielke, and W. Sterry, “Adhesion molecular mapping in normal human skin,” Archives of Dermatological Research, vol. 281, no. 7, pp. 454–462, 1989.
- M. D. Hertle, J. C. Adams, and F. M. Watt, “Integrin expression during human epidermal development in vivo and in vitro,” Development, vol. 112, no. 1, pp. 193–206, 1991.
- L. E. Goldfinger, S. B. Hopkinson, G. W. Dehart, S. Collawn, J. R. Couchman, and J. C. R. Jones, “The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin,” Journal of Cell Science, vol. 112, no. 16, pp. 2615–2629, 1999.
- F. M. Watt, “Role of integrins in regulating epidermal adhesion, growth and differentiation,” The EMBO Journal, vol. 21, no. 15, pp. 3919–3926, 2002.
- G. E. Plopper, S. Z. Domanico, V. Cirulli, W. B. Kiosses, and V. Quaranta, “Migration of breast epithelial cells on laminin-5: differential role of integrins in normal and transformed cell types,” Breast Cancer Research and Treatment, vol. 51, no. 1, pp. 57–69, 1998.
- N. Pouliot, E. C. Nice, and A. W. Burgess, “Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via α3β1 and α6β4 integrins,” Experimental Cell Research, vol. 266, no. 1, pp. 1–10, 2001.
- N. Pouliot and N. Kusuma, “Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis,” Cell Adhesion and Migration, vol. 7, no. 1, pp. 142–149, 2013.
- K. R. Legate and R. Fässler, “Mechanisms that regulate adaptor binding to β-integrin cytoplasmic tails,” Journal of Cell Science, vol. 122, no. 2, pp. 187–198, 2009.
- E. Karaköse, H. B. Sciller, and R. Fässler, “The kindlins at a glance,” Journal of Cell Science, vol. 123, pp. 2353–2356, 2010.
- S. Estrach, L. Cailleteau, C. A. Franco et al., “Laminin-binding integrins induce DII4 expression and Notch signaling in endothelial cells,” Circulation Research, vol. 109, pp. 172–182, 2011.
- H. Qu, T. Wen, M. Pesch, and M. Aumailley, “Partial loss of epithelial phenotype in kindling-1-deficient keratinocytes,” The American Journal of Pathology, vol. 180, no. 4, pp. 1581–1592, 2012.
- S. A. Wickström, A. Lange, E. Montanez, and R. Fässler, “The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!,” The EMBO Journal, vol. 29, no. 2, pp. 281–291, 2010.
- L. Borradori and A. Sonnenberg, “Structure and function of hemidesmosomes: more than simple adhesion complexes,” Journal of Investigative Dermatology, vol. 112, no. 4, pp. 411–418, 1999.
- S. H. M. Litjens, J. M. de Pereda, and A. Sonnenberg, “Current insights into the formation and breakdown of hemidesmosomes,” Trends in Cell Biology, vol. 16, no. 7, pp. 376–383, 2006.
- K. Wilhelmsen, S. H. M. Litjens, and A. Sonnenberg, “Multiple functions of the integrin α6β4 in epidermal homeostasis and tumorigenesis,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 2877–2886, 2006.
- T. Tennenbaum, A. K. Weiner, A. J. Belanger, A. B. Glick, H. Hennings, and S. H. Yuspa, “The suprabasal expression of α6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis,” Cancer Research, vol. 53, no. 20, pp. 4803–4810, 1993.
- P. Tomakidi, N. Mirancea, N. E. Fusenig, C. Herold-Mende, F. X. Bosch, and D. Breitkreutz, “Defects of basement membrane and hemidesmosome structure correlate with malignant phenotype and stromal interactions in HaCaT-Ras xenografts,” Differentiation, vol. 64, no. 5, pp. 263–275, 1999.
- M. P. Marinkovich, “Tumour microenvironment: laminin 332 in squamous-cell carcinoma,” Nature Reviews Cancer, vol. 7, no. 5, pp. 370–380, 2007.
- A. Li, N. Pouliot, R. Redvers, and P. Kaur, “Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny,” Journal of Clinical Investigation, vol. 113, no. 3, pp. 390–400, 2004.
- A. Domogatskaya, S. Rodin, A. Boutaud, and K. Tryggvason, “Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro,” Stem Cells, vol. 26, no. 11, pp. 2800–2809, 2008.
- E. Fuchs, “Finding one's niche in the skin,” Cell Stem Cell, vol. 4, no. 6, pp. 499–502, 2009.
- J. T. Connelly, A. Mishra, J. E. Gautrot, and F. M. Watt, “Shape-induced terminal differentiation of human epidermal stem cells requires p38 and is regulated by histone acetylation,” PLoS ONE, vol. 6, no. 11, Article ID e27259, 2011.
- H. Fujiwara, M. Ferreira, G. Donati et al., “The basement membrane of hair follicle stem cells is a muscle cell niche,” Cell, vol. 144, no. 4, pp. 577–589, 2011.
- K. Boehnke, B. Falkowska-Hansen, H.-J. Stark, and P. Boukamp, “Stem cells of the human epidermis and their niche: composition and function in epidermal regeneration and carcinogenesis,” Carcinogenesis, vol. 33, no. 7, pp. 1247–1258, 2012.
- B. Trappmann, J. E. Gautrot, J. T. Connelly et al., “Extracellular-matrix tethering regulates stem-cell fate,” Nature Materials, vol. 11, no. 7, pp. 642–649, 2012.
- R. Timpl and J. C. Brown, “Supramolecular assembly of basement membranes,” BioEssays, vol. 18, no. 2, pp. 123–132, 1996.
- P. D. Yurchenco, Y. S. Cheng, and G. C. Ruben, “Self-assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers,” The Journal of Biological Chemistry, vol. 262, no. 36, pp. 17668–17676, 1987.
- J. Kruegel and N. Miosge, “Basement membrane components are key players in specialized extracellular matrices,” Cellular and Molecular Life Sciences, vol. 67, no. 17, pp. 2879–2895, 2010.
- E. Hohenester and P. D. Yurchenco, “Laminins in basement membrane assembly,” Cell Adhesion and Migration, vol. 7, no. 1, pp. 56–63, 2013.
- M. Aumailley and P. Rousselle, “Laminins of the dermo-epidermal junction,” Matrix Biology, vol. 18, no. 1, pp. 19–28, 1999.
- J. H. Miner and P. D. Yurchenco, “Laminin functions in tissue morphogenesis,” Annual Review of Cell and Developmental Biology, vol. 20, pp. 255–284, 2004.
- M. Aumailley, L. Bruckner-Tuderman, W. G. Carter et al., “A simplified laminin nomenclature,” Matrix Biology, vol. 24, no. 5, pp. 326–332, 2005.
- L. F. Yousif, J. Di Russo, and L. Sorokin, “Laminin isoforms in endothelial and perivascular basement membranes,” Cell Adhesion and Migration, vol. 7, no. 1, pp. 101–110, 2013.
- P. D. Yurchenco, Y. S. Cheng, and H. Colognato, “Laminin forms an independent network in basement membranes,” Journal of Cell Biology, vol. 117, no. 5, pp. 1119–1133, 1992.
- R. Timpl, M. Dziadek, S. Fujiwara, H. Nowack, and G. Wick, “Nidogen: a new, self-aggregating basement membrane protein,” European Journal of Biochemistry, vol. 137, no. 3, pp. 455–465, 1983.
- M. Paulsson, “The role of Ca2+ binding in the self-aggregation of laminin-nidogen complexes,” The Journal of Biological Chemistry, vol. 263, no. 11, pp. 5425–5430, 1988.
- D. T. Behrens, D. Villone, M. Koch et al., “The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens,” The Journal of Biological Chemistry, vol. 287, no. 22, pp. 18700–18709, 2012.
- B. J. Dzamba, D. R. Keene, Z. Isogai et al., “Assembly of epithelial cell fibrillins,” Journal of Investigative Dermatology, vol. 117, no. 6, pp. 1612–1620, 2001.
- K. Tiedemann, T. Sasaki, E. Gustafsson et al., “Microfibrils at basement membrane zones interact with perlecan via fibrillin-1,” The Journal of Biological Chemistry, vol. 280, no. 12, pp. 11404–11412, 2005.
- C. Bonod-Bidaud, M. Roulet, U. Hansen et al., “In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface,” Journal of Investigative Dermatology, vol. 132, no. 7, pp. 1841–1849, 2012.
- N. Miosge, T. Simniok, P. Sprysch, and R. Herken, “The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo,” Journal of Histochemistry and Cytochemistry, vol. 51, no. 3, pp. 285–296, 2003.
- S. Sercu, M. Zhang, N. Oyama et al., “Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin,” Journal of Investigative Dermatology, vol. 128, no. 6, pp. 1397–1408, 2008.
- J. Merregaert, J. van Langen, U. Hansen et al., “Phospholipid scramblase 1 is secreted by a lipid raft-dependent pathway and interacts with the extracellular matrix protein 1 in the dermal epidermal junction zone of human skin,” The Journal of Biological Chemistry, vol. 285, no. 48, pp. 37823–37837, 2010.
- P. D. Yurchenco and Y. S. Cheng, “Self-assembly and calcium-binding sites in laminin, a three-arm interaction model,” The Journal of Biological Chemistry, vol. 268, no. 23, pp. 17286–17299, 1993.
- J. H. O. Garbe, W. Göhring, K. Mann, R. Timpl, and T. Sasaki, “Complete sequence, analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin α3B and α5 chains,” Biochemical Journal, vol. 362, no. 1, pp. 213–221, 2002.
- K. K. McKee, D. Harrison, S. Capizzi, and P. D. Yurchenco, “Role of laminin terminal globular domains in basement membrane assembly,” The Journal of Biological Chemistry, vol. 282, no. 29, pp. 21437–21447, 2007.
- J. H. Miner, “Laminins and their role in development,” Microscopy Research and Technique, vol. 71, no. 5, pp. 349–356, 2008.
- P. D. Yurchenco and G. C. Ruben, “Basement membrane structure in situ: evidence for lateral associations in the type IV collagen network,” Journal of Cell Biology, vol. 105, no. 6 I, pp. 2559–2568, 1987.
- E. Pöschl, U. Schlötzer-Schrehardt, B. Brachvogel, K. Saito, Y. Ninomiya, and U. Mayer, “Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development,” Development, vol. 131, no. 7, pp. 1619–1628, 2004.
- N. Smyth, S. H. Vatansever, P. Murray et al., “Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation,” Journal of Cell Biology, vol. 144, no. 1, pp. 151–160, 1999.
- J. H. Miner, C. Li, J. L. Mudd, G. Go, and A. E. Sutherland, “Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation,” Development, vol. 131, no. 10, pp. 2247–2256, 2004.
- J. W. Fox, U. Mayer, R. Nischt et al., “Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV,” The EMBO Journal, vol. 10, no. 11, pp. 3137–3146, 1991.
- C. Battaglia, U. Mayer, M. Aumailley, and R. Timpl, “Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core,” European Journal of Biochemistry, vol. 208, no. 2, pp. 359–366, 1992.
- M. Aumailley, C. Battaglia, U. Mayer et al., “Nidogen mediates the formation of ternary complexes of basement membrane components,” Kidney International, vol. 43, no. 1, pp. 7–12, 1993.
- N. Ettner, W. Göhring, T. Sasaki, K. Mann, and R. Timpl, “The N-terminal globular domain of the laminin α1 chain binds to α1β1 and α2β1 integrins and to the heparan sulfate-containing domains of perlecan,” The FEBS Letters, vol. 430, no. 3, pp. 217–221, 1998.
- M. Bechtel, M. V. Keller, W. Bloch et al., “Different domains in nidogen-1 and nicdogen-2 drive basement membrane formation in skin organotypic cocultures,” The FASEB Journal, vol. 26, no. 9, pp. 3637–3648, 2012.
- E. Arikawa-Hirasawa, H. Watanabe, H. Takami, J. R. Hassell, and Y. Yamada, “Perlecan is essential for cartilage and cephalic development,” Nature Genetics, vol. 23, no. 3, pp. 354–358, 1999.
- M. Costell, E. Gustafsson, A. Aszódi et al., “Perlecan maintains the integrity of cartilage and some basement membranes,” Journal of Cell Biology, vol. 147, no. 5, pp. 1109–1122, 1999.
- B. L. Bader, N. Smyth, S. Nedbal et al., “Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice,” Molecular and Cellular Biology, vol. 25, no. 15, pp. 6846–6856, 2005.
- B. Carlin, R. Jaffe, B. Bender, and A. E. Chung, “Entactin, a novel basal lamina-associated sulfated glycoprotein,” The Journal of Biological Chemistry, vol. 256, no. 10, pp. 5208–5214, 1981.
- N. Kimura, T. Toyoshima, T. Kojima, and M. Shimane, “Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen,” Experimental Cell Research, vol. 241, no. 1, pp. 36–45, 1998.
- E. Kohfeldt, T. Sasaki, W. Göhring, and R. Timpl, “Nidogen-2: a new basement membrane protein with diverse binding properties,” Journal of Molecular Biology, vol. 282, no. 1, pp. 99–109, 1998.
- K. Salmivirta, J. F. Talts, M. Olsson, T. Sasaki, R. Timpl, and P. Ekblom, “Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens,” Experimental Cell Research, vol. 279, no. 2, pp. 188–201, 2002.
- M. S. P. Ho, K. Böse, S. Mokkapati, R. Nischt, and N. Smyth, “Nidogens-extracellular matrix linker molecules,” Microscopy Research and Technique, vol. 71, no. 5, pp. 387–395, 2008.
- E. Pöschl, J. W. Fox, D. Block, U. Mayer, and R. Timpl, “Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain,” The EMBO Journal, vol. 13, no. 16, pp. 3741–3747, 1994.
- Y. Kadoya, K. Salmivirta, J. F. Talts et al., “Importance of nidogen binding to laminin γ1 for branching epithelial morphogenesis of the submandibular gland,” Development, vol. 124, no. 3, pp. 683–691, 1997.
- N. Gersdorff, E. Kohfeldt, T. Sasaki, R. Timpl, and N. Miosge, “Laminin γ3 chain binds to nidogen and is located in murine basement membranes,” The Journal of Biological Chemistry, vol. 280, no. 23, pp. 22146–22153, 2005.
- S. Mokkapati, A. Fleger-Weckmann, M. Bechtel et al., “Basement membrane deposition of nidogen 1 but not nidogen 2 requires the nidogen binding module of the laminin γ1 chain,” The Journal of Biological Chemistry, vol. 286, no. 3, pp. 1911–1918, 2011.
- J. M. Whitelock, J. Melrose, and R. V. Iozzo, “Diverse cell signaling events modulated by perlecan,” Biochemistry, vol. 47, no. 43, pp. 11174–11183, 2008.
- N. Mirancea, I. Hausser, D. Metze, H. J. Stark, P. Boukamp, and D. Breitkreutz, “Junctional basement membrane anomalies of skin and mucosa in lipoid proteinosis (hyalinosis cutis et mucosae),” Journal of Dermatological Science, vol. 45, no. 3, pp. 175–185, 2007.
- S. Paquet-Fifield, H. Schlüter, A. Li et al., “A role for pericytes as microenvironmental regulators of human skin tissue regeneration,” Journal of Clinical Investigation, vol. 119, no. 9, pp. 2795–2806, 2009.
- L. M. T. Sterk, C. A. W. Geuijen, L. C. J. M. Oomen, J. Calafat, H. Janssen, and A. Sonnenberg, “The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin α6β4 and may regulate the spatial organization of hemidesmosomes,” Journal of Cell Biology, vol. 149, no. 4, pp. 969–982, 2000.
- A. Sonnenberg, J. Calafat, H. Janssen et al., “Integrin α6/β4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion,” Journal of Cell Biology, vol. 113, no. 4, pp. 907–917, 1991.
- L. M. T. Sterk, C. A. W. Geuijen, J. G. van den Berg, N. Claessen, J. J. Weening, and A. Sonnenberg, “Association of the tetraspanin CD151 with the laminin-binding integrins α3β1, α6Β1, α6β4 and α7β1 in cells in culture and in vivo,” Journal of Cell Science, vol. 115, no. 6, pp. 1161–1173, 2002.
- C. W. Franzke, P. Bruckner, and L. Bruckner-Tuderman, “Collagenous transmembrane proteins: recent insights into biology and pathology,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4005–4008, 2005.
- H. Qiao, A. Shibaki, H. A. Long et al., “Collagen XVII participates in keratinocyte adhesion to collagen IV, and in p38MAPK-dependent migration and cell signaling,” Journal of Investigative Dermatology, vol. 129, no. 9, pp. 2288–2295, 2009.
- W. Nishie, D. Kiritsi, A. Nyström, S. C. Hofmann, and L. Bruckner-Tuderman, “Dynamic interactions of epidermal collagen XVII with extracellular matrix,” The American Journal of Pathology, vol. 179, no. 2, pp. 829–837, 2011.
- K. Sugawara, D. Tsuruta, M. Ishii, J. C. R. Jones, and H. Kobayashi, “Laminin-332 and -511 in skin,” Experimental Dermatology, vol. 17, no. 6, pp. 473–480, 2008.
- L. E. Goldfinger, M. S. Stack, and J. C. R. Jones, “Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator,” Journal of Cell Biology, vol. 141, no. 1, pp. 255–265, 1998.
- S. Amano, I. C. Scott, K. Takahara et al., “Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ2 chain,” The Journal of Biological Chemistry, vol. 275, no. 30, pp. 22728–22735, 2000.
- M. Hormia, J. Falk-Marzillier, G. Plopper, R. N. Tamura, J. C. R. Jones, and V. Quaranta, “Rapid spreading and mature hemidesmosome formation in HaCaT keratinocytes induced by incubation with soluble laminin-5r,” Journal of Investigative Dermatology, vol. 105, no. 4, pp. 557–561, 1995.
- G. Plopper, J. Falk-Marzillier, S. Glaser et al., “Changes in expression of monoclonal antibody epitopes on laminin-5r induced by cell contact,” Journal of Cell Science, vol. 109, no. 7, pp. 1965–1973, 1996.
- E. Hintermann and V. Quaranta, “Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors,” Matrix Biology, vol. 23, no. 2, pp. 75–85, 2004.
- H. Schneider, C. Mühle, and F. Pacho, “Biological function of laminin-5 and pathogenic impact of its deficiency,” European Journal of Cell Biology, vol. 86, no. 11-12, pp. 701–717, 2007.
- M. Tripathi, S. Nandana, H. Yamashita, R. Ganesan, D. Kirchhofer, and V. Quaranta, “Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression,” The Journal of Biological Chemistry, vol. 283, no. 45, pp. 30576–30584, 2008.
- T. Ozawa, D. Tsuruta, J. C. R. Jones et al., “Dynamic relationship of focal contacts and hemidesmosome protein complexes in live cells,” Journal of Investigative Dermatology, vol. 130, no. 6, pp. 1624–1635, 2010.
- N. E. Winterwood, A. Varzavand, M. N. Meland, L. K. Ashman, and C. S. Stipp, “A critical role for tetraspanin CD151 in α3β1 and α6β4 integrin-dependent tumor cell functions on laminin-5,” Molecular Biology of the Cell, vol. 17, no. 6, pp. 2707–2721, 2006.
- N. Koshikawa, T. Minegishi, A. Sharabi, V. Quaranta, and M. Seiki, “Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin γ2 chain,” The Journal of Biological Chemistry, vol. 280, no. 1, pp. 88–93, 2005.
- X. M. Shen, Y. P. Wu, Y. B. Feng et al., “Interaction of MT1-MMP and laminin-5γ2 chain correlates with metastasis and invasiveness in human esophageal squamous cell carcinoma,” Clinical and Experimental Metastasis, vol. 24, no. 7, pp. 541–550, 2007.
- D. P. Veitch, P. Nokelainen, K. A. McGowan et al., “Mammalian tolloid metalloproteinase, and not matrix metalloproteinase 2 or membrane type 1 metalloproteinase, processes laminin-5 in keratinocytes and skin,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15661–15668, 2003.
- P. Rousselle, D. R. Keene, F. Ruggiero, M. F. Champliaud, M. D. van Rest, and R. E. Burgeson, “Laminin 5 binds the NC-1 domain of type VII collagen,” Journal of Cell Biology, vol. 138, no. 3, pp. 719–728, 1997.
- L. Bruckner-Tuderman, “Hereditary skin diseases of anchoring fibrils,” Journal of Dermatological Science, vol. 20, no. 2, pp. 122–133, 1999.
- D. Villone, A. Fritsch, M. Koch, L. Bruckner-Tuderman, U. Hansen, and P. Bruckner, “Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils,” The Journal of Biological Chemistry, vol. 283, no. 36, pp. 24506–24513, 2008.
- A. Fritsch, S. Spassov, S. Elfert et al., “Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII,” The Journal of Biological Chemistry, vol. 284, no. 44, pp. 30248–30256, 2009.
- M. Aumailley, C. Has, L. Tunggal, and L. Bruckner-Tuderman, “Molecular basis of inherited skin-blistering disorders, and therapeutic implications,” Expert Reviews in Molecular Medicine, vol. 8, no. 24, pp. 1–21, 2006.
- P. Chaudhari and M. P. Marinkovich, “What's new in blistering disorders?” Current Allergy and Asthma Reports, vol. 7, no. 4, pp. 255–263, 2007.
- M. P. Marinkovich, D. R. Keene, C. S. Rimberg, and R. E. Burgeson, “Cellular origin of the dermal-epidermal basement membrane,” Developmental Dynamics, vol. 197, no. 4, pp. 255–267, 1993.
- P. Ekblom, M. Ekblom, L. Fecker et al., “Role of mesenchymal nidogen for epithelial morphogenesis in vitro,” Development, vol. 120, no. 7, pp. 2003–2014, 1994.
- R. Fleischmajer, A. Schechter, E. D. MacDonald et al., “Skin fibroblasts are the only source of nidogen during early basal lamina formation in vitro,” Journal of Investigative Dermatology, vol. 105, no. 4, pp. 597–601, 1995.
- J. H. Miner, B. L. Patton, S. I. Lentz et al., “The laminin α chains: expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8–11, and cloning of a novel α3 isoform,” Journal of Cell Biology, vol. 137, no. 3, pp. 685–701, 1997.
- C. Spenlé, P. Simon-Assmann, G. Orend, and J. H. Miner, “Laminin α5 guides tissue patterning and organogenesis,” Cell Adhesion and Migration, vol. 7, no. 1, pp. 90–100, 2013.
- R. Nischt, C. Schmidt, N. Mirancea et al., “Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture,” Journal of Investigative Dermatology, vol. 127, no. 3, pp. 545–554, 2007.
- T. Tani, V. P. Lehto, and I. Virtanen, “Expression of laminins 1 and 10 in carcinoma cells and comparison of their roles in cell adhesion,” Experimental Cell Research, vol. 248, no. 1, pp. 115–121, 1999.
- I. Virtanen, D. Gullberg, J. Rissanen et al., “Laminin α1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues,” Experimental Cell Research, vol. 257, no. 2, pp. 298–309, 2000.
- M. Murshed, N. Smyth, N. Miosge et al., “The absence of nidogen 1 does not affect murine basement membrane formation,” Molecular and Cellular Biology, vol. 20, no. 18, pp. 7007–7012, 2000.
- J. Schymeinsky, S. Nedbal, N. Miosge et al., “Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice,” Molecular and Cellular Biology, vol. 22, no. 19, pp. 6820–6830, 2002.
- N. Miosge, T. Sasaki, and R. Timpl, “Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice,” Matrix Biology, vol. 21, no. 7, pp. 611–621, 2002.
- L. Dong, Y. Chen, M. Lewis et al., “Neurologic defects and selective disruption of basement membranes in mice lacking entactin-1/nidogen-1,” Laboratory Investigation, vol. 82, no. 12, pp. 1617–1630, 2002.
- R. Köhling, R. Nischt, A. Vasudevan et al., “Nidogen and nidogen-associated basement membrane proteins and neuronal plasticity,” Neurodegenerative Diseases, vol. 3, no. 1-2, pp. 56–61, 2006.
- A. Vasudevan, M. S. P. Ho, M. Weiergräber et al., “Basement membrane protein nidogen-1 shapes hippocampal synaptic plasticity and excitability,” Hippocampus, vol. 20, no. 5, pp. 608–620, 2010.
- M. Willem, N. Miosge, W. Halfter et al., “Specific ablation of the nidogen-binding site in the laminin γ1 chain interferes with kidney and lung development,” Development, vol. 129, no. 11, pp. 2711–2722, 2002.
- N. Mirancea, I. Hausser, R. Beck, D. Metze, N. E. Fusenig, and D. Breitkreutz, “Vascular anomalies in lipoid proteinosis (hyalinosis cutis et mucosae): basement membrane components and ultrastructure,” Journal of Dermatological Science, vol. 42, no. 3, pp. 231–239, 2006.
- D. Breitkreutz, A. Bohnert, E. Herzmann, P. E. Bowden, P. Boukamp, and N. E. Fusenig, “Differentiation specific functions in cultured and transplanted mouse keratinocytes: environmental influences on ultrastructure and keratin expression,” Differentiation, vol. 26, no. 2, pp. 154–169, 1984.
- D. Breitkreutz, J. Hornung, J. Pohlmann et al., “Environmental induction of differentiation-specific keratins in malignant mouse keratinocyte lines,” European Journal of Cell Biology, vol. 42, no. 2, pp. 255–267, 1986.
- P. Boukamp, D. Breitkreutz, H. J. Stark, and N. E. Fusenig, “Mesenchyme-mediated and endogenous regulation of growth and differentiation of human skin keratinocytes derived from different body sites,” Differentiation, vol. 44, no. 2, pp. 150–161, 1990.
- P. Boukamp, R. T. Dzarlieva-Petrusevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig, “Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line,” Journal of Cell Biology, vol. 106, no. 3, pp. 761–771, 1988.
- C. M. Ryle, D. Breitkreutz, H. J. Stark et al., “Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones,” Differentiation, vol. 40, no. 1, pp. 42–54, 1989.
- D. Breitkreutz, H. J. Stark, P. Plein, M. Baur, and N. E. Fusenig, “Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+,” Differentiation, vol. 54, no. 3, pp. 201–217, 1993.
- D. Breitkreutz, P. Boukamp, C. M. Ryle, H. J. Stark, D. R. Roop, and N. E. Fusenig, “Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line,” Cancer Research, vol. 51, no. 16, pp. 4402–4409, 1991.
- A. Limat, D. Breitkreutz, G. Thiekoetter et al., “Formation of a regular neo-epidermis by cultured human outer root sheath cells grafted on nude mice,” Transplantation, vol. 59, no. 7, pp. 1032–1038, 1995.
- A. Limat, E. Stockhammer, D. Breitkreutz et al., “Endogeneously regulated site-specific differentiation of human palmar skin keratinocytes in organotypic cocultures and in nude mouse transplants,” European Journal of Cell Biology, vol. 69, no. 3, pp. 245–258, 1996.
- D. Breitkreutz, H. J. Stark, N. Mirancea, P. Tomakidi, H. Steinbauer, and N. E. Fusenig, “Integrin and basement membrane normalization in mouse grafts of human keratinocytes—implications for epidermal homeostasis,” Differentiation, vol. 61, no. 3, pp. 195–209, 1997.
- D. Breitkreutz, V. M. Schoop, N. Mirancea, M. Baur, H. J. Stark, and N. E. Fusenig, “Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants,” European Journal of Cell Biology, vol. 75, no. 3, pp. 273–286, 1998.
- P. Tomakidi, H. J. Stark, C. Herold-Mende et al., “Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions,” Journal of Pathology, vol. 200, no. 3, pp. 298–307, 2003.
- S. Vosseler, N. Mirancea, P. Bohlen, M. M. Mueller, and N. E. Fusenig, “Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants,” Cancer Research, vol. 65, no. 4, pp. 1294–1305, 2005.
- P. V. Iyer and A. S. Y. Leong, “Poorly differentiated squamous cell carcinomas of the skin can express vimentin,” Journal of Cutaneous Pathology, vol. 19, no. 1, pp. 34–39, 1992.
- D. Breitkreutz, L. Braiman-Wiksman, N. Daum, M. F. Denning, and T. Tennenbaum, “Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium,” Journal of Cancer Research and Clinical Oncology, vol. 133, no. 11, pp. 793–808, 2007.
- N. Mirancea, C. Schmidt, N. Daum et al., “Basement membrane defects in xeno-grafts of malignant human cells,” in Proceedings of the 2nd International Conference on Tumor Microenvironment, I. P. Witz, Ed., pp. 55–58, Monduzzi, Bologna, Italy, 2002.
- K. Kiyoshima, Y. Oda, N. Kinukawa, S. Naito, and M. Tsuneyoshi, “Overexpression of laminin-5 γ2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor, and human epidermal growth factor 2,” Human Pathology, vol. 36, no. 5, pp. 522–530, 2005.
- P. Richter, C. Umbreit, M. Franz et al., “EGF/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332,” Journal of Oral Pathology and Medicine, vol. 40, no. 1, pp. 46–54, 2011.
- D. Asselineau, B. A. Bernard, C. Bailly, and M. Darmon, “Retinoic acid improves epidermal morphogenesis,” Developmental Biology, vol. 133, no. 2, pp. 322–335, 1989.
- R. Fleischmajer, J. S. Perlish, E. D. MacDonald II et al., “There is binding of collagen IV to β1 integrin during early skin basement membrane assembly,” Annals of the New York Academy of Sciences, vol. 857, pp. 212–227, 1998.
- R. Fleischmajer, K. Kuroda, A. Utani et al., “Differential expression of laminin α chains during proliferative and differentiation stages in a model for skin morphogenesis,” Matrix Biology, vol. 19, no. 7, pp. 637–647, 2000.
- R. Fleischmajer, A. Utani, E. D. MacDonald II et al., “Initiation of skin basement membrane formation at the epidermo-dermal interface involves assembly of laminins through binding to cell membrane receptors,” Journal of Cell Science, vol. 111, no. 14, pp. 1929–1940, 1998.
- H. Smola, H. J. Stark, G. Thiekötter, N. Mirancea, T. Krieg, and N. E. Fusenig, “Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture,” Experimental Cell Research, vol. 239, no. 2, pp. 399–410, 1998.
- H. J. Stark, M. Baur, D. Breitkreutz, N. Mirancea, and N. E. Fusenig, “Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiation,” Journal of Investigative Dermatology, vol. 112, no. 5, pp. 681–691, 1999.
- A. Szabowski, N. Maas-Szabowski, S. Andrecht et al., “c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin,” Cell, vol. 103, no. 5, pp. 745–755, 2000.
- N. Maas-Szabowski, A. Szabowski, H. J. Stark et al., “Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation,” Journal of Investigative Dermatology, vol. 116, no. 5, pp. 816–820, 2001.
- M. Sadagurski, S. Yakar, G. Weingarten et al., “Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation,” Molecular and Cellular Biology, vol. 26, no. 7, pp. 2675–2687, 2006.
- C. E. Barton, K. N. Johnson, D. M. Mays et al., “Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation,” Cell Death and Disease, vol. 1, no. 9, article e74, 2010.
- H. J. Stark, M. J. Willhauck, N. Mirancea et al., “Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermo-epidermal junction in organotypic co-culture,” European Journal of Cell Biology, vol. 83, no. 11-12, pp. 631–645, 2004.
- D. Breitkreutz, N. Mirancea, C. Schmidt et al., “Inhibition of basement membrane formation by a nidogen-binding laminin γ1-chain fragment in human skin-organotypic cocultures,” Journal of Cell Science, vol. 117, no. 12, pp. 2611–2622, 2004.
- A. El Ghalbzouri, M. F. Jonkman, R. Dijkman, and M. Ponec, “Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes,” Journal of Investigative Dermatology, vol. 124, no. 1, pp. 79–86, 2005.
- C. Marionnet, C. Pierrard, C. Vioux-Chagnoleau, J. Sok, D. Asselineau, and F. Bernerd, “Interactions between fibroblasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin,” Journal of Investigative Dermatology, vol. 126, no. 5, pp. 971–979, 2006.
- F. Di Nunzio, G. Maruggi, S. Ferrari et al., “Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors,” Molecular Therapy, vol. 16, no. 12, pp. 1977–1985, 2008.
- E. M. Murauer, Y. Gache, I. K. Gratz et al., “Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa,” Journal of Investigative Dermatology, vol. 131, no. 1, pp. 74–83, 2011.
- A. Botta, F. Delteil, A. Mettouchi et al., “Confluence switch signaling regulates ECM composition and plasmin proteolytic cascade in keratinocytes,” Journal of Cell Science, vol. 125, pp. 4241–4252, 2012.
- U. Mayer, K. Mann, R. Timpl, and G. Murphy, “Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling,” European Journal of Biochemistry, vol. 217, no. 3, pp. 877–884, 1993.
- R. R. Lareu, I. Arsianti, H. K. Subramhanya, P. Yanxian, and M. Raghunath, “In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study,” Tissue Engineering, vol. 13, no. 2, pp. 385–391, 2007.
- N. Pouliot, N. A. Saunders, and P. Kaur, “Laminin 10/11: an alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration,” Experimental Dermatology, vol. 11, no. 5, pp. 387–397, 2002.
- C. M. Alexander, E. W. Howard, M. J. Bissell, and Z. Werb, “Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene,” Journal of Cell Biology, vol. 135, no. 6 I, pp. 1669–1677, 1996.
- P. Pujuguet, M. Simian, J. Liaw, R. Timpl, Z. Werb, and M. J. Bissell, “Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression,” Journal of Cell Science, vol. 113, no. 5, pp. 849–858, 2000.
- A. Baranowsky, S. Mokkapati, M. Bechtel et al., “Impaired wound healing in mice lacking the basement membrane protein nidogen 1,” Matrix Biology, vol. 29, no. 1, pp. 15–21, 2010.
- S. Dedhar, K. Jewell, M. Rojiani, and V. Gray, “The receptor for the basement membrane glycoprotein entactin is the integrin α3/β1,” The Journal of Biological Chemistry, vol. 267, no. 26, pp. 18908–18914, 1992.
- L. J. Dong, J. C. Hsieh, and A. E. Chung, “Two distinct cell attachment sites in entactin are revealed by amino acid substitutions and deletion of the RGD sequence in the cysteine-rich epidermal growth factor repeat 2,” The Journal of Biological Chemistry, vol. 270, no. 26, pp. 15838–15843, 1995.
- H. D. Gresham, I. L. Graham, G. L. Griffin et al., “Domain-specific interactions between entactin and neutrophil integrins: G2 domain ligation of integrin α3β1 and E domain ligation of the leukocyte response integrin signal for different responses,” The Journal of Biological Chemistry, vol. 271, no. 48, pp. 30587–30594, 1996.
- J. Thyboll, J. Kortesmaa, R. Cao et al., “Deletion of the laminin α4 chain leads to impaired microvessel maturation,” Molecular and Cellular Biology, vol. 22, no. 4, pp. 1194–1202, 2002.
- R. Hallmann, N. Horn, M. Selg, O. Wendler, F. Pausch, and L. M. Sorokin, “Expression and function of laminins in the embryonic and mature vasculature,” Physiological Reviews, vol. 85, no. 3, pp. 979–1000, 2005.
- D. Stenzel, C. A. Franco, S. Estrach et al., “Endothelial basement membrane limits tip cell formation by inducing DII4/notch signalling in vivo,” EMBO Reports, vol. 12, pp. 1135–1143, 2011.
- Z. Zhou, M. Doi, J. Wang et al., “Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice,” Cancer Research, vol. 64, no. 12, pp. 4059–4063, 2004.
- N. Ortega and Z. Werb, “New functional roles for non-collagenous domains of basement membrane collagens,” Journal of Cell Science, vol. 115, no. 22, pp. 4201–4214, 2002.
- M. S. O'Reilly, T. Boehm, Y. Shing et al., “Endostatin: an endogenous inhibitor of angiogenesis and tumor growth,” Cell, vol. 88, no. 2, pp. 277–285, 1997.
- R. Kalluri, “Basement membranes: structure, assembly and role in tumour angiogenesis,” Nature Reviews Cancer, vol. 3, no. 6, pp. 422–433, 2003.
- A. G. Marneros and B. R. Olsen, “Physiological role of collagen XVIII and endostatin,” FASEB Journal, vol. 19, no. 7, pp. 716–728, 2005.
- P. Nyberg, L. Xie, and R. Kalluri, “Endogenous inhibitors of angiogenesis,” Cancer Research, vol. 65, no. 10, pp. 3967–3979, 2005.
- M. Sund, Y. Hamano, H. Sugimoto et al., “Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 8, pp. 2934–2939, 2005.
- A. Nyström, Z. P. Shaik, D. Gullberg et al., “Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity,” Blood, vol. 114, no. 23, pp. 4897–4906, 2009.
- L. Xie, M. B. Duncan, J. Pahler et al., “Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 24, pp. 9939–9944, 2011.
- P. Zigrino, O. Ayachi, A. Schild et al., “Loss of epidermal MMP-14 expression interferes with angiogenesis but not with re-epithelialization,” European Journal of Cell Biology, vol. 91, no. 10, pp. 748–756, 2012.
- H. Wang, W. Fu, J. H. Im et al., “Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis,” Journal of Cell Biology, vol. 164, no. 6, pp. 935–941, 2004.
- S. Ortiz-Urda, J. Garcia, C. L. Green et al., “Type VII collagen is required for ras-driven human epidermal tumorigenesis,” Science, vol. 307, no. 5716, pp. 1773–1776, 2005.
- M. Tran, P. Rousselle, P. Nokelainen et al., “Targeting a tumor-specific laminin domain critical for human carcinogenesis,” Cancer Research, vol. 68, no. 8, pp. 2885–2894, 2008.
- U. Rodeck and J. Uitto, “Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis,” Journal of Investigative Dermatology, vol. 127, no. 10, pp. 2295–2296, 2007.
- J. Li, J. Tzu, Y. Chen et al., “Laminin-10 is crucial for hair morphogenesis,” The EMBO Journal, vol. 22, no. 10, pp. 2400–2410, 2003.
- J. Gao, M. C. DeRouen, C. H. Chen et al., “Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis,” Genes and Development, vol. 22, no. 15, pp. 2111–2124, 2008.
- T. Tumbar, G. Guasch, V. Greco et al., “Defining the epithelial stem cell niche in skin,” Science, vol. 303, no. 5656, pp. 359–363, 2004.
- P. Kaur, “Interfollicular epidermal stem cells: identification, challenges, potential,” Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1450–1458, 2006.
- M. Ito and G. Cotsarelis, “Is the hair follicle necessary for normal wound healing?” Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1059–1061, 2008.
- S. J. Morrison and A. C. Spradling, “Stem cells and niches: mechanisms that promote stem cell maintenance throughout life,” Cell, vol. 132, no. 4, pp. 598–611, 2008.
- Y. C. Hsu and E. Fuchs, “A family business: stem cell progeny join the niche to regulate homeostasis,” Nature Reviews Molecular Cell Biology, vol. 13, no. 2, pp. 103–114, 2012.
- A. W. Lund, J. P. Stegemann, and G. E. Plopper, “Mesenchymal stem cells sense three dimensional type I collagen through discoidin domain receptor 1,” Open Stem Cell Journal, vol. 1, pp. 40–53, 2009.
- M. Angstmann, I. Brinkmann, K. Bieback, D. Breitkreutz, and C. Maercker, “Monitoring human mesenchymal stromal cell differentiation by electrochemical impedance sensing,” Cytotherapy, vol. 13, no. 9, pp. 1074–1089, 2011.
- S. Li, D. Harrison, S. Carbonetto et al., “Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation,” Journal of Cell Biology, vol. 157, no. 7, pp. 1279–1290, 2002.
- S. Muffler, H. J. Stark, M. Amoros et al., “A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures,” Stem Cells, vol. 26, no. 10, pp. 2506–2515, 2008.
- J. Sok, N. Pineau, M. Dalko-Csiba, L. Breton, and F. Bernerd, “Improvement of the dermal epidermal junction in human reconstructed skin by a new c-xylopyranoside derivative,” European Journal of Dermatology, vol. 18, no. 3, pp. 297–302, 2008.
- U. Mayer, K. Zimmermann, K. Mann, D. Reinhardt, R. Timpl, and R. Nischt, “Binding properties and protease stability of recombinant human nidogen,” European Journal of Biochemistry, vol. 227, no. 3, pp. 681–686, 1995.
- M. N. Kruse, C. Becker, D. Lottaz et al., “Human meprin α and β homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors,” Biochemical Journal, vol. 378, no. 2, pp. 383–389, 2004.
- N. Geurts, C. Becker-Pauly, E. Martens, P. Proost, P. E. Van Den Steen, and W. Stöcker, “Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3,” The FEBS Letters, vol. 586, no. 24, pp. 4264–4269, 2012.
- J. Sage, E. Leblanc-Noblesse, C. Nizard et al., “Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners,” PLoS ONE, vol. 7, no. 8, Article ID e43494, 2012.
Copyright © 2013 Dirk Breitkreutz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.